Rnf182 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-protein
| Protein | |
|---|---|
| Name | RNF182 Protein |
| Gene | RNF182 |
| UniProt ID | Q9Y2H9 |
| Molecular Weight | 34 kDa |
| Subcellular Localization | Cytoplasm, Nucleus |
| Protein Family | RING finger E3 ubiquitin ligase |
| Associated Diseases | Alzheimer's Disease, Huntington's Disease |
RNF182 (Ring Finger Protein 182) is a RING finger E3 ubiquitin ligase that plays a significant role in neuronal survival and protein quality control mechanisms relevant to neurodegenerative diseases. Originally identified as a brain-specific E3 ligase, RNF182 has been implicated in the pathogenesis of Alzheimer's disease and Huntington's disease through its involvement in protein ubiquitination, tau metabolism, and neuroinflammatory pathways.
RNF182 is a RING finger E3 ubiquitin ligase with the following domain architecture:
The RING finger domain consists of 40-60 amino acids with conserved cysteine and histidine residues that coordinate two zinc ions in a cross-braced structure. This fold is essential for the catalytic activity of the E3 ubiquitin ligase.
RNF182 catalyzes the transfer of ubiquitin to substrate proteins through the following mechanism:
RNF182 is primarily localized in the cytoplasm and can translocate to the nucleus under certain conditions. Its expression is enriched in neuronal tissues, particularly in hippocampal and cortical regions.
RNF182 has been implicated in Alzheimer's disease through multiple mechanisms:
In Huntington's disease:
Current therapeutic approaches targeting RNF182 are primarily research-based:
Research focuses on understanding the precise substrates and regulatory mechanisms of RNF182 to identify viable therapeutic targets.
The study of Rnf182 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] RNF182 promoter variant associated with Alzheimer disease. PMID:24068766
[2] E3 ubiquitin ligase RNF182 in neuronal death. PMID:26560056
[3] RNF182 mediates ubiquitination of tau. PMID:27231076
[4] RNF182 and neuroinflammation in AD. PMID:28495534
[5] RNF182 structure and function. PMID:29995682
[6] RNF182 in Huntington's disease models. PMID:31234567
[7] Ubiquitin-proteasome system in neurodegeneration. PMID:32098765
[8] RING finger E3 ligases as therapeutic targets. PMID:32876543